Spiriva Respimat

Spiriva Respimat Chỉ định/Công dụng

tiotropium bromide

Nhà sản xuất:

Boehringer Ingelheim
Thông tin kê toa chi tiết tiếng Anh
Indications/Uses
COPD: SPIRIVA RESPIMAT is indicated for the maintenance treatment of patients with COPD (including chronic bronchitis and emphysema), the maintenance treatment of associated dyspnoea, the improvement of COPD compromised quality of life and reduction of exacerbations.
Asthma: SPIRIVA RESPIMAT is indicated as add-on maintenance treatment for the improvement of asthma symptoms in adult patients with asthma who are currently treated with the maintenance combination of inhaled corticosteroids and long acting beta2 agonists and who experienced one or more severe exacerbations in the previous year.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in